Evidence map›Paper›PMID 40984997›Full record

ArticleEuropean heart journal. Digital health2025

Deep learning for atrioventricular regurgitation diagnosis: an external validation study.

Ido Cohen, Jeffrey G Malins, Michal Cohen-Shelly, Yossi Asaf, Michael Fiman, Kobi Faierstein, Lior Fisher, Karin Sudri, Ehud Raanani, Ehud Schwammenthal and 2 more

Abstract read
In one paragraph

Article in European heart journal. Digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ido CohenLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.ORCID https://orcid.org/0000-0003-4528-8194
Jeffrey G MalinsDepartment of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.ORCID https://orcid.org/0000-0002-2932-256X
Michal Cohen-ShellyLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Yossi AsafLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Michael FimanAisap.ai, Derech Sheba 2, Ramat Gan 5266202, Israel.
Kobi FaiersteinLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Lior FisherLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Karin SudriARC Innovation Center, Sagol AI Hub, Sheba Medical Center, Derech  Sheba  2, Ramat Gan  52621, Israel.
Ehud RaananiLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Ehud SchwammenthalLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Robert KlempfnerLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.
Elad MaorLeviev Cardiovascular Institute, Sheba Medical Center, Derech Sheba 2, Tel HaShomer, Ramat Gan 52621, Israel.ORCID https://orcid.org/0000-0002-5087-0464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Mitral and tricuspid regurgitation (MR and TR) are common in older adults and associated with substantial morbidity and mortality. While transthoracic echocardiography (TTE) is the diagnostic gold standard, access remains limited in many care settings. Artificial intelligence (AI)-based echocardiographic analysis may help address this diagnostic gap. Methods and results: We externally validated a deep learning algorithm developed by Aisap.ai using TTE studies from the Mayo Clinic Health System (2013-23). The model analyses echocardiographic images to classify atrioventricular regurgitation severity and was evaluated against cardiologist interpretations. Performance was assessed using binary (normal-mild vs. moderate-severe) and ordinal (normal, mild, moderate, severe) classification schemes. Among 1541 eligible TTEs, the model returned predictions for 578 studies (38%). Performance analysis was limited to these cases. The MR cohort included 280 studies and the TR cohort 298. For MR, the model achieved an area under the receiver operating characteristic curve (AUC) of 0.98 [95% confidence interval (CI): 0.97-0.99], with 91% accuracy, 95% sensitivity, and 89% specificity. For TR, the AUC was 0.96 (95% CI: 0.94-0.98), with 84% accuracy, 91% sensitivity, and 80% specificity. Conclusion: In cases where a prediction was generated, the model demonstrated high diagnostic performance in identifying clinically significant atrioventricular regurgitation. These findings support the feasibility of AI-assisted echocardiography in diverse populations, while underscoring the need for technical alignment between model requirements and local acquisition practices to ensure real-world applicability.

Indexed as

Artificial intelligenceAtrioventricular valve regurgitationEchocardiographyExternal validationMachine learningMitral regurgitationTricuspid regurgitation

Identifiers

PMID40984997
PMCPMC12450501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.